论文部分内容阅读
作者采用微生物代谢产物（Biologicals369,BC369）对38例恶性胸腔积液进行治疗，临床资料证明：完全反应（CR）率为92．1％（35／38），部分反应（PR）率为7．9％（3／38），总反应（CR＋PR）率为100％（38／38）。结果提示BC369对恶性胸腔积液有一定的治疗作用。
The authors used microbial metabolites (Biologicals369, BC369) to treat 38 cases of malignant pleural effusion. Clinical data showed that the complete response (CR) rate was 92.1% (35/38), and the partial response (PR) rate was 7. At 9% (3/38), the overall response (CR+PR) rate was 100% (38/38). The results suggest that BC369 has a certain therapeutic effect on malignant pleural effusion.